http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
우리나라 야생조류의 체내 납(Pb)과 카드뮴(Cd) 축척
김정수,신주렬,이화수,구태회 경희대학교 2006 環境硏究 論文集 Vol.15 No.-
This study presents concentrations of lead and cadmium in liver and kidney in Korean wild birds during 2000-2002. Lead concentrations in livers were Kharadriiformes < Anserifoimes < Kiconiiformes < Falconiformes < Passeriformes < Columbiformes. Their lead concentrations in livers and kidneys was within background level and exposed level. Cadmium concentrations in kidneys were Kharadriiformes < Ciconiiformes < Anseriformes < Falconiformes < Passeriformes < Columbifoimes. Kidney cadmium concentrations in Korean wild birds were within the range of background level, but one Cattle Egret Bibulous ibis and 7 Ancient Murrelet Synthliboramphus antiques was toxic level.
포스터 전시 : 상부위장관 ; 드문 임상양상을 보인 십이지장 중복낭(Duodenal Duplication Cyst) 3예
김현수 ( Kim Hyeon Su ),주광로 ( Ju Gwang Lo ),신수진 ( Sin Su Jin ),우순주 ( U Sun Ju ),박종호 ( Park Jong Ho ),신정우 ( Sin Jeong U ),방성조 ( Bang Seong Jo ),김도하 ( Kim Do Ha ),박능화 ( Park Neung Hwa ) 대한소화기학회 2003 대한소화기학회 추계학술대회 Vol.2003 No.-
위장관 중복낭은 주로 소아에서 발견되는 드문 선천성 기형으로 위장관 어디에서나 발생될 수 있으나 회장 말단이 가장 흔히 발생되는 장소이며 십이지장에서 발생하는 경우는 4~12%로 주로 구부와 2부에 국한되어 발생한다. 임상양상은 장 폐색이 주된 소견이며 이외 폐쇄성 황달, 췌장염, 출혈, 및 천공 등이 드물게 나타날 수 있다. 본 증례는 성인에서 발견되고 병리학적으로 확진된 십이지장 중복낭 3예로 각각 폐쇄성 황달 및 췌장염, 재발성 췌장염, 출혈과 천
Combination Therapy of Sophoraflavanone B against MRSA: <i>In Vitro</i> Synergy Testing
Mun, Su-Hyun,Kang, Ok-Hwa,Joung, Dae-Ki,Kim, Sung-Bae,Seo, Yun-Soo,Choi, Jang-Gi,Lee, Young-Seob,Cha, Seon-Woo,Ahn, Young-Sup,Han, Sin-Hee,Kwon, Dong-Yeul Hindawi Publishing Corporation 2013 Evidence-based Complementary and Alternative Medic Vol.2013 No.-
<P>Sophoraflavanone B (SPF-B), a known prenylated flavonoid, was isolated from the roots of <I>Desmodium caudatum</I>. The aim of this study was to determine the antimicrobial synergism of SPF-B combined with antibiotics against methicillin-resistant <I>Staphylococcus aureus</I> (MRSA). MRSA, a multidrug-resistant pathogen, causes both hospital- and community-acquired infections worldwide. The antimicrobial activity of SPF-B was assessed by the broth microdilution method, checkerboard dilution test, and time-kill curve assay. The MIC of SPF-B for 7 strains of <I>S. aureus</I> ranges from 15.6 to 31.25 <I><I>μ</I></I>g/mL determined. In the checkerboard method, the combinations of SPF-B with antibiotics had a synergistic effect; SPF-B markedly reduced the MICs of the <I><I>β</I></I>-lactam antibiotics: ampicillin (AMP) and oxacillin (OXI); aminoglycosides gentamicin (GET); quinolones ciprofloxacin (CIP) and norfloxacin (NOR) against MRSA. The time-kill curves assay showed that a combined SPF-B and selected antibiotics treatment reduced the bacterial counts below the lowest detectable limit after 24 h. These data suggest that the antibacterial activity of SPF-B against MRSA can be effectively increased through its combination with three groups of antibiotics (<I><I>β</I></I>-lactams, aminoglycosides, and quinolones). Our research can be a valuable and significant source for the development of a new antibacterial drug with low MRSA resistance.</P>